Internal motions prime cIAP1 for rapid activation

被引:17
作者
Phillips, Aaron H. [1 ]
Schoeffler, Allyn J. [1 ]
Matsui, Tsutomu [2 ]
Weiss, Thomas M. [2 ]
Blankenship, John W. [1 ]
Zobel, Kerry [1 ]
Giannetti, Anthony M. [3 ]
Dueber, Erin C. [1 ]
Fairbrother, Wayne J. [1 ]
机构
[1] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA
[2] Stanford Linear Accelerator Ctr Natl Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA
[3] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA
基金
美国国家卫生研究院;
关键词
STRUCTURAL BASIS; IAP ANTAGONISTS; CONFORMATIONAL-CHANGE; E3; LIGASE; SMAC; APOPTOSIS; PROTEINS; INDUCE; RECOGNITION; INHIBITOR;
D O I
10.1038/nsmb.2916
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular inhibitor of apoptosis 1 (cIAP1) is a ubiquitin ligase with critical roles in the control of programmed cell death and NF-kappa B signaling. Under normal conditions, the protein exists as an autoinhibited monomer, but proapoptotic signals lead to its dimerization, activation and proteasomal degradation. This view of clAP1 as a binary switch has been informed by static structural studies that cannot access the protein's dynamics. Here, we use NMR spectroscopy to study micro- and millisecond motions of specific domain interfaces in human clAP1 and use time-resolved small-angle X-ray scattering to observe the global conformational changes necessary for activation. Although motions within each interface of the 'closed' monomer are insufficient to activate clAP1, they enable associations with catalytic partners and activation factors. We propose that these internal motions facilitate rapid peptide-induced opening and dimerization of clAP1, which undergoes a dramatic spring-loaded structural transition.
引用
收藏
页码:1068 / 1074
页数:7
相关论文
共 31 条
  • [1] Structural characterization of flexible proteins using small-angle X-ray scattering
    Bernado, Pau
    Mylonas, Efstratios
    Petoukhov, Maxim V.
    Blackledge, Martin
    Svergun, Dmitri I.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (17) : 5656 - 5664
  • [2] cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination
    Bertrand, Mathieu J. M.
    Milutinovic, Snezana
    Dickson, Kathleen M.
    Ho, Wai Chi
    Boudreault, Alain
    Durkin, Jon
    Gillard, John W.
    Jaquith, James B.
    Morris, Stephen J.
    Barker, Philip A.
    [J]. MOLECULAR CELL, 2008, 30 (06) : 689 - 700
  • [3] A SPRING-LOADED MECHANISM FOR THE CONFORMATIONAL CHANGE OF INFLUENZA HEMAGGLUTININ
    CARR, CM
    KIM, PS
    [J]. CELL, 1993, 73 (04) : 823 - 832
  • [4] BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer
    Dou, Hao
    Buetow, Lori
    Sibbet, Gary J.
    Cameron, Kenneth
    Huang, Danny T.
    [J]. NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2012, 19 (09) : 876 - 883
  • [5] Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
    Du, CY
    Fang, M
    Li, YC
    Li, L
    Wang, XD
    [J]. CELL, 2000, 102 (01) : 33 - 42
  • [6] Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination
    Dueber, Erin C.
    Schoeffler, Allyn J.
    Lingel, Andreas
    Elliott, J. Michael
    Fedorova, Anna V.
    Giannetti, Anthony M.
    Zobel, Kerry
    Maurer, Brigitte
    Varfolomeev, Eugene
    Wu, Ping
    Wallweber, Heidi J. A.
    Hymowitz, Sarah G.
    Deshayes, Kurt
    Vucic, Domagoj
    Fairbrother, Wayne J.
    [J]. SCIENCE, 2011, 334 (6054) : 376 - 380
  • [7] Smac Mimetics Activate the E3 Ligase Activity of cIAP1 Protein by Promoting RING Domain Dimerization
    Feltham, Rebecca
    Bettjeman, Bodhi
    Budhidarmo, Rhesa
    Mace, Peter D.
    Shirley, Sarah
    Condon, Stephen M.
    Chunduru, Srinivas K.
    McKinlay, Mark A.
    Vaux, David L.
    Silke, John
    Day, Catherine L.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (19) : 17015 - 17028
  • [8] Small-molecule pan-IAP antagonists: a patent review
    Flygare, John A.
    Fairbrother, Wayne J.
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (02) : 251 - 267
  • [9] Programmed Cell Death in Animal Development and Disease
    Fuchs, Yaron
    Steller, Hermann
    [J]. CELL, 2011, 147 (04) : 742 - 758
  • [10] Targeting IAP proteins for therapeutic intervention in cancer
    Fulda, Simone
    Vucic, Domagoj
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (02) : 109 - 124